September 25, 2024
The Midnight Bathroom Run From Hell – a patient’s story
- /
- /
When you can’t walk, a simple middle-of-the-night trip to the bathroom is anything but. By Mona Sen For My Health Story…
MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.
September 24, 2024
The Effect of Seasonal Changes on Multiple Sclerosis
- /
- /
- /
Do you experience more MS symptoms in some seasons than others? Many of us do, says the blogger Trevis Gleason,…
September 22, 2024
A Case Study in Neurotherapeutic Clinical Trial Design and Conduct
- /
- /
September 2024 New phase 1 trial showcases Neurological Institute’s interdisciplinary study capabilities Early this summer, Cleveland Clinic researchers enrolled the…
September 22, 2024
Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
- /
- /
- /
- /
- /
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
September 22, 2024
Could Serum Neurofilament Light (sNFL) Chain Level Help Guide MS Management?
- /
- /
April 2024 Perhaps, with caveats: sNfL elevation has low sensitivity and lags MRI activity by at least a month Serum…
September 22, 2024
When Multiple Sclerosis Is Suspected in Patients Under 18 or Over 50
- /
- /
September 17, 2024 Guidance from international committee on differential diagnoses and diagnostic approach Approximately 85% of cases of multiple sclerosis…
September 21, 2024
First Evidence of Delayed Disability Progression in Non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS)
- /
The BTK inhibitor tolebrutinib meets its primary endpoint in phase 3 HERCULES trial For the first time, a medication has…
September 21, 2024
Factors Influencing Time Delays in Initiating High-Efficacy Treatment in Multiple Sclerosis: Valentin Krüger, MD
- /
- /
- /
- /
September 19, 2024 By Valentin Krüger, MD / Isabella Ciccone, MPH — Fact checked by Marco Meglio The neurology resident at the…
September 18, 2024
New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients
- /
- /
Sep 18, 2024 East Hanover, September 18, 2024 – Novartis today announced new data from the ALITHIOS open-label extension study. Data…
September 17, 2024
Insomnia and MS: Expert Approaches to Better Sleep
- /
Feeling fatigued? Take a look at how multiple sclerosis can affect your sleep and the actions you can take today…
